Your browser doesn't support javascript.
loading
Efficacy of venetoclax monotherapy in patients with relapsed chronic lymphocytic leukaemia in the post-BCR inhibitor setting: a UK wide analysis.
Eyre, Toby A; Kirkwood, Amy A; Gohill, Sat; Follows, George; Walewska, Renata; Walter, Harriet; Cross, Matthew; Forconi, Francesco; Shah, Nimish; Chasty, Richard; Hart, Alistair; Broom, Angus; Marr, Helen; Patten, Piers E M; Dann, Andy; Arumainathan, Arvind; Munir, Tal; Shankara, Paneesha; Bloor, Adrian; Johnston, Rosalynd; Orchard, Kim; Schuh, Anna H; Fox, Christopher P.
Afiliación
  • Eyre TA; Department of Haematology, Churchill Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
  • Kirkwood AA; Cancer Research UK & UCL Cancer Trials Centre, UCL, London, UK.
  • Gohill S; Department of Haematology, University College London Hospitals, London, UK.
  • Follows G; Department of Haematology, Addenbrooke's Hospital NHS Trust, Cambridge, UK.
  • Walewska R; Department of Haematology, Royal Bournemouth Hospital, Bournemouth, UK.
  • Walter H; Department of Haematology, Leicester Royal Infirmary, Leicester, UK.
  • Cross M; Department of Haematology, The Royal Marsden Hospital, London, UK.
  • Forconi F; Haematology Department, University Hospital Trust and Cancer Sciences Unit, Cancer Research UK and National Institute for Health Research Experimental Cancer Medicine Centres, Faculty of Medicine, University of Southampton, Southampton, UK.
  • Shah N; Department of Haematology, Norfolk and Norwich University Hospital National Health Service Trust, Norwich, UK.
  • Chasty R; Department of Haematology, University Hospitals of North Midlands NHS Trust, Stoke-on-Trent, UK.
  • Hart A; Department of Haematology, Queen Elizabeth University Hospital, Glasgow, UK.
  • Broom A; Department of Haematology, Western General Hospital, Edinburgh, UK.
  • Marr H; Department of Haematology, Freeman Hospital, Newcastle on Tyne, UK.
  • Patten PEM; Department of Haematological Medicine, Kings College Hospital, London, UK.
  • Dann A; Department of Haemato-Oncology, The Ipswich Hospital NHS Trust, Ipswich, UK.
  • Arumainathan A; Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, UK.
  • Munir T; Department of Haematology, St James's University Hospital, Leeds, UK.
  • Shankara P; Department of Haematology, Heartlands Hospital, Birmingham, UK.
  • Bloor A; Department of Haematology, The Christie Hospital NHS Trust, Manchester, UK.
  • Johnston R; Department of Haematology, Royal Sussex County Hospital, Brighton, UK.
  • Orchard K; Department of Haematology and Bone Marrow Transplantation, University Hospital Southampton, Southampton, UK.
  • Schuh AH; Department of Haematology, Churchill Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
  • Fox CP; Oxford Molecular Diagnostic Centre, Department of Oncology, University of Oxford, John Radcliffe Hospital, Oxford, UK.
Br J Haematol ; 185(4): 656-669, 2019 05.
Article en En | MEDLINE | ID: mdl-30768675
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Sulfonamidas / Leucemia Linfocítica Crónica de Células B / Compuestos Bicíclicos Heterocíclicos con Puentes / Antineoplásicos Tipo de estudio: Observational_studies / Risk_factors_studies País/Región como asunto: Europa Idioma: En Revista: Br J Haematol Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Sulfonamidas / Leucemia Linfocítica Crónica de Células B / Compuestos Bicíclicos Heterocíclicos con Puentes / Antineoplásicos Tipo de estudio: Observational_studies / Risk_factors_studies País/Región como asunto: Europa Idioma: En Revista: Br J Haematol Año: 2019 Tipo del documento: Article